Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes

Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice

Anti-ganglioside GM[2] monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes

Augmentation by bispecific F(ab')[2] reactive with P-glyco-protein and CD3 of cytotoxicity of human effector cells on P-glycoprotein positive human renal cancer cells